CVS Health (NYSE:CVS) has really grown to be more than a pharmacy as it now has almost 1,000 walk-in medical clinics offering check-ups, screenings and immunizations, among others. It is also a leading pharmacy benefit manager and now has over 70 million members in its pharmacy benefit plan. The company continues to grow and I recently got behind the company after its latest earnings report is exactly what prompted me to weigh in on the company. The company has seen a growth in sales which reflects the aging population, the rising number of prescriptions being written in the United States, as well as effective marketing in the retail segment to offset the loss of tobacco sales. The company is firing on all cylinders. In Q1 net revenues were up 11.1%, or $3.6 billion year-over-year. They came in at to $36.3 billion for Q1 2015. Factoring in expenses, net income increased 8.1%, to $1.2 billion, compared to $1.1 billion for Q1 2014. This translates to $1.07 in earnings, up from the $0.95 last year. Factoring in adjustments to the GAAP net income, adjusted earnings were $1.14, rising 12.2% from the $1.02 last year. CVS delivered results that surpassed my expectations. Read more